ValuentumAd

Official PayPal Seal

Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Nov 5, 2013
Dividend Growth Portfolio Holding Emerson Hikes Dividend!
One of the better performers in the Dividend Growth portfolio raised its dividend today.
Nov 5, 2013
Phillips 66’s 3Q Reveals Difficult Refining Environment
Phillips 66's volatile refining earnings coupled with management's decision to forgo additional debt repayment translate into too much risk for us. We're looking for an exit point in one of the biggest winners in the portfolio of our Dividend Growth Newsletter.
Nov 3, 2013
Surveying 3Q Results at the Energy Majors
ConocoPhillips’ profit gain leads the energy majors, but the investment landscape remains mixed.
Nov 2, 2013
Valuentum's November Edition of Its Dividend Growth Newsletter!
The November edition of our Dividend Growth Newsletter is now available.
Nov 1, 2013
The Curious Cases of Intuitive Surgical and Teva Pharma: What We Have Learned
Let’s talk about what we’ve learned about our process as a result of Intuitive Surgical and Teva Pharma.
Oct 31, 2013
The Valuentum Dividend Cushion Predicts CONSOL’s Dividend Cut
The Valuentum Dividend Cushion continues to showcase its efficacy as a dividend growth investing tool.
Oct 25, 2013
Surveying 3Q Performance from Big Pharma: Bristol-Myers, Eli Lilly, and AbbVie
Let’s take a look at the third-quarter performance of a few pharmaceutical firms.
Oct 25, 2013
Dividend Increases for the Week Ending October 25
Let's take a look at dividend increases for the week ending October 25.
Oct 25, 2013
The Tale of Three Valuentum Buying Index Ratings of 9
Let’s take a look at how three firms with near-perfect VBI ratings performed in their respective third quarters: Deluxe, NASDAQ OMX, and USG.
Oct 18, 2013
Facebook: The New Internet?
Let’s take a look at what we think Facebook might be in a decade or so.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.